Last $28.86 USD
Change Today +0.16 / 0.56%
Volume 31.3M
PFE On Other Exchanges
Symbol
Exchange
New York
Xetra
Mexico
SIX Swiss Ex
Stockholm
London
Sao Paulo
Bogota
As of 8:04 PM 08/1/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ian C. Read

Chairman, Chief Executive Officer and Chairman of Executive Committee, Pfizer Inc.
AgeTotal Calculated CompensationThis person is connected to 121 board members in 5 different organizations across 4 different industries.

See Board Relationships
60$18,947,747
As of Fiscal Year 2013

Background*

Mr. Ian C. Read has been Chief Executive Officer of Pfizer Inc., since December 5, 2010. Mr. Read served as the President of Pfizer Inc. from December 5, 2010 to December 12, 2011. He is the Chairman and Chief Executive Officer at Thiakis Limited. He served as Group President of Worldwide Biopharmaceutical Businesses at Pfizer Inc. since October 2009. He served as Senior Vice President of Pfizer Inc. from August 2006 to December 5, 2010. He served as President of Worldwide ...

Read Full Background

Corporate Headquarters*

235 East 42nd Street
New York, New York 10017

United States

Phone: 212-733-2323
Fax: --

Board Members Memberships*

Director
Director
Chairman and Chief Executive Officer
2007-Present
Outside Director, Chairman of Nominating & Corporate Governance Committee and Member of Executive Committee
2010-Present
Chairman, Chief Executive Officer and Chairman of Executive Committee

Education*

BS 1974
University Of London

Other Affiliations*

Annual Compensation*

Salary$1,776,250
Total Annual Compensation$1,776,250

Stock Options*

Restricted Stock Awards$6,016,528
All Other Compensation$476,300
Exercised Options338,000
Exercised Options Value$1,474,749
Exercisable Options415,000
Exercisable Options Value$1,345,000
Total Value of Options$2,819,749
Total Number of Options753,000

Total Compensation*

Total Annual Cash Compensation$5,652,550
Total Short Term Compensation$1,776,250
Other Long Term Compensation$6,492,828
Total Calculated Compensation$18,947,747
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFE:US $28.86 USD +0.16

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Alan George Lafley Chairman of the Board, Chief Executive Officer, President and Member of Proxy Committee
The Procter & Gamble Company
$1.8M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
$1.5M
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.3M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.